BioRestorative Therapies, Inc. SEC filings BRTX

BioRestorative Therapies, Inc. has 754 filings in SEC EDGAR's recent list, going back to Nov 16, 2010. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (officer or director change). The company's fiscal year ends on December 31.

BioRestorative Therapies, Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Oct 9, 2026 Oct 7, 2026
8-K Current report
Officer or director change
Sep 11, 2026 Sep 4, 2026
8-K/A Amended current report
Auditor change, Other events
Sep 10, 2026 Aug 26, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Sep 2, 2026 Sep 2, 2026
8-K Current report
Auditor change, Officer or director change
Sep 2, 2026 Aug 26, 2026
8-K Current report
Listing notice
Aug 25, 2026 Aug 21, 2026
NT 10-Q Filing Aug 14, 2026 Jun 30, 2026
8-K Current report
Other events
Aug 14, 2026 Aug 7, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 3, 2026 —
3 Initial insider ownership Jul 30, 2026 Jul 13, 2026
3 Initial insider ownership Jul 24, 2026 Jul 14, 2026
8-K Current report
Officer or director change
Jul 16, 2026 Jul 8, 2026
3 Initial insider ownership Jun 18, 2026 Jun 10, 2026
3 Initial insider ownership Jun 18, 2026 Jun 10, 2026
3 Initial insider ownership Jun 17, 2026 Jun 10, 2026
8-K Current report
Officer or director change
Jun 12, 2026 Jun 10, 2026
8-K Current report
Material agreement, Officer or director change
Jun 12, 2026 Jun 10, 2026
8-K Current report
Officer or director change, Shareholder vote results
May 29, 2026 May 26, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Officer or director change
May 1, 2026 May 1, 2026
424B3 Prospectus Apr 30, 2026 —
EFFECT Filing Apr 28, 2026 —
POS AM Filing Apr 27, 2026 —
8-K Current report
Regulation FD disclosure
Apr 23, 2026 Apr 23, 2026
POS AM Filing Apr 20, 2026 —
DEF 14A Proxy statement Apr 13, 2026 May 26, 2026
PRE 14A Preliminary proxy statement Apr 3, 2026 May 26, 2026
10-K Annual report Mar 26, 2026 Dec 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 23, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 18, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Feb 17, 2026 Feb 11, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 13, 2026 —
424B4 Prospectus Feb 13, 2026 —
EFFECT Filing Feb 11, 2026 —
CORRESP Letter to the SEC Feb 10, 2026 —
S-1/A Amended registration statement Feb 10, 2026 —
S-1 Registration statement Feb 9, 2026 —
DRS Filing Dec 19, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Dec 19, 2025 —
424B3 Prospectus Dec 12, 2025 —
EFFECT Filing Dec 10, 2025 —
CORRESP Letter to the SEC Dec 8, 2025 —
S-8 Employee stock plan registration Nov 18, 2025 —
S-1 Registration statement Nov 18, 2025 —
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 12, 2025 Nov 12, 2025
4 Insider transaction Oct 20, 2025 Oct 6, 2025
4 Insider transaction Oct 20, 2025 Oct 6, 2025
D Filing Oct 9, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Oct 8, 2025 Oct 6, 2025
424B5 Prospectus supplement Oct 8, 2025 —
424B5 Prospectus supplement Oct 6, 2025 —
8-K Current report
Shareholder vote results
Sep 25, 2025 Sep 18, 2025
8-K Current report
Regulation FD disclosure
Aug 14, 2025 Aug 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 12, 2025 Aug 12, 2025
DEF 14A Proxy statement Aug 8, 2025 Aug 8, 2025
8-K Current report
Regulation FD disclosure
Jun 13, 2025 Jun 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 14, 2025 May 14, 2025
8-K Current report
Auditor change
Apr 21, 2025 Apr 16, 2025
10-K Annual report Mar 28, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Mar 27, 2025 Mar 27, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 28, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 19, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 19, 2025 —
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 19, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2025 —
8-K Current report
Regulation FD disclosure
Feb 10, 2025 Feb 10, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Dec 5, 2024 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
8-K Current report
Results of operations, Regulation FD disclosure
Nov 13, 2024 Nov 12, 2024
S-8 Employee stock plan registration Nov 13, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Regulation FD disclosure
Nov 7, 2024 Nov 6, 2024
8-K Current report
Material agreement, Agreement ended
Nov 6, 2024 Nov 1, 2024
424B5 Prospectus supplement Nov 6, 2024 —
10-K/A Amended annual report Nov 6, 2024 Dec 31, 2023
4 Insider transaction Nov 5, 2024 Oct 28, 2024
8-K Current report
Shareholder vote results
Sep 23, 2024 Sep 19, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 13, 2024 Aug 13, 2024
DEF 14A Proxy statement Aug 8, 2024 Sep 19, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 6, 2024 Aug 6, 2024
SCHEDULE 13G Ownership over 5% (passive) Jun 21, 2024 —
10-Q Quarterly report Jun 11, 2024 Mar 31, 2024
10-K/A Amended annual report Jun 11, 2024 Dec 31, 2023
8-K Current report
Listing notice
May 24, 2024 May 22, 2024
8-K Current report
Restatement
May 24, 2024 May 23, 2024
NT 10-Q March 31, 2024 May 16, 2024 Mar 31, 2024
424B3 Prospectus Apr 19, 2024 —
EFFECT Filing Apr 18, 2024 —
CORRESP Letter to the SEC Apr 17, 2024 —
S-1/A Amended registration statement Apr 12, 2024 —
UPLOAD Letter from the SEC Apr 11, 2024 —
4 Insider transaction Apr 10, 2024 Apr 8, 2024
S-1 Registration statement Apr 3, 2024 —
10-K Annual report Apr 1, 2024 Dec 31, 2023
4 Insider transaction Mar 20, 2024 Mar 18, 2024
4 Insider transaction Mar 20, 2024 Mar 18, 2024
8-K Current report
Regulation FD disclosure
Mar 12, 2024 Mar 11, 2024
SC 13D/A Amended ownership over 5% (active) Mar 6, 2024 —
SC 13D/A Amended ownership over 5% (active) Feb 15, 2024 —
SC 13D/A Amended ownership over 5% (active) Feb 15, 2024 —
4 Insider transaction Feb 15, 2024 Feb 13, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
4 Insider transaction Feb 12, 2024 Feb 8, 2024
4 Insider transaction Feb 9, 2024 Feb 7, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Feb 8, 2024 Feb 6, 2024
8-K Current report
Regulation FD disclosure
Feb 5, 2024 Feb 5, 2024
8-K Current report
Regulation FD disclosure
Feb 1, 2024 Feb 1, 2024
4 Insider transaction Dec 5, 2023 Dec 1, 2023
4 Insider transaction Dec 1, 2023 Nov 27, 2023
S-8 Employee stock plan registration Nov 15, 2023 —
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
4 Insider transaction Sep 18, 2023 Sep 14, 2023
4 Insider transaction Sep 18, 2023 Sep 15, 2023
8-K Current report
Shareholder vote results
Sep 15, 2023 Sep 13, 2023
4 Insider transaction Sep 14, 2023 Jul 28, 2023
4 Insider transaction Sep 13, 2023 Sep 13, 2023
4 Insider transaction Sep 6, 2023 Sep 6, 2023
4 Insider transaction Aug 31, 2023 Aug 31, 2023
424B5 Prospectus supplement Aug 23, 2023 —
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
DEF 14A Proxy statement Aug 4, 2023 Sep 13, 2023
4 Insider transaction Jul 28, 2023 Jul 27, 2023
4 Insider transaction Jul 25, 2023 Jul 25, 2023
8-K Current report
Material agreement, Other events
Jul 13, 2023 Jul 11, 2023
424B5 Prospectus supplement Jul 13, 2023 —
424B5 Prospectus supplement Jul 11, 2023 —
424B5 Prospectus supplement May 15, 2023 —
10-Q Quarterly report May 12, 2023 Mar 31, 2023
8-K Current report
Material agreement
Apr 14, 2023 Apr 14, 2023
424B2 Prospectus Apr 14, 2023 —
8-K Current report
Other events
Apr 6, 2023 Apr 6, 2023
4 Insider transaction Apr 4, 2023 Mar 31, 2023
S-8 Employee stock plan registration Mar 28, 2023 —
10-K Annual report Mar 27, 2023 Dec 31, 2022
4 Insider transaction Mar 22, 2023 Mar 20, 2023
4 Insider transaction Mar 22, 2023 Mar 20, 2023
4 Insider transaction Mar 3, 2023 Nov 30, 2022
4 Insider transaction Feb 28, 2023 Feb 18, 2023
4 Insider transaction Feb 27, 2023 Feb 18, 2023
4 Insider transaction Feb 17, 2023 Feb 17, 2023
4 Insider transaction Feb 17, 2023 Feb 17, 2023
4 Insider transaction Feb 17, 2023 Feb 17, 2023
4 Insider transaction Feb 17, 2023 Feb 17, 2023
4 Insider transaction Feb 17, 2023 Feb 17, 2023
4 Insider transaction Feb 17, 2023 Feb 17, 2023
4 Insider transaction Feb 17, 2023 Feb 17, 2023
SC 13D/A Amended ownership over 5% (active) Feb 17, 2023 —
SC 13D/A Amended ownership over 5% (active) Feb 17, 2023 —
EFFECT Filing Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
CORRESP Letter to the SEC Feb 13, 2023 —
S-3/A Amendment 1 Feb 13, 2023 —
UPLOAD Letter from the SEC Feb 10, 2023 —
S-3 Shelf registration Feb 7, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 7, 2023 —
4 Insider transaction Feb 2, 2023 Feb 1, 2023
4 Insider transaction Jan 30, 2023 Jan 27, 2023
4 Insider transaction Jan 24, 2023 Jan 20, 2023
4 Insider transaction Jan 20, 2023 Jan 18, 2023
4 Insider transaction Jan 10, 2023 Jan 9, 2023
8-K Current report
Change to shareholder rights
Jan 5, 2023 Dec 29, 2022
4 Insider transaction Dec 28, 2022 Dec 23, 2022
4 Insider transaction Dec 7, 2022 Dec 7, 2022
4 Insider transaction Nov 21, 2022 Nov 21, 2022
4 Insider transaction Nov 21, 2022 Nov 18, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Shareholder vote results
Nov 9, 2022 Nov 3, 2022
4 Insider transaction Nov 4, 2022 Nov 3, 2022
4 Insider transaction Nov 4, 2022 Nov 3, 2022
4 Insider transaction Nov 4, 2022 Nov 3, 2022
4 Insider transaction Nov 4, 2022 Nov 3, 2022
4 Insider transaction Nov 4, 2022 Nov 3, 2022
4 Insider transaction Nov 4, 2022 Nov 3, 2022
4 Insider transaction Nov 4, 2022 Nov 3, 2022
4 Insider transaction Oct 12, 2022 Oct 12, 2022
4 Insider transaction Oct 12, 2022 Oct 11, 2022
EFFECT Filing Oct 4, 2022 —
POS AM Amendment 1 to post effective amendment 1 to form s-1 on form s-3 Sep 30, 2022 —
4 Insider transaction Sep 27, 2022 Sep 23, 2022
DEF 14A Proxy statement Sep 23, 2022 Nov 3, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Misc Health & Allied Services, NEC (SIC 8090)
Listed as
BRTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Melville, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1505497
Former names
Stem Cell Assurance, Inc. (until Aug 16, 2011)

Other Services-Misc Health & Allied Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.